Catalyst

Slingshot members are tracking this event:

Tracon (TCON) Presents Phase 2 Data Evaluating TRC105 in Recurrent Glioblastoma (GBM)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TCON

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 10, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2, Trc105, Recurrent Glioblastoma